Genetically Modified Chickens That Overexpress Defensin Peptides Resist Salmonella and Other Pathogens

Researchers used Tol-2 transposon technology to genetically modify chickens to overexpress either ovotransferrin or avian β-defensin-3. They confirmed transgene expression at the RNA and protein level across multiple tissues. Antimicrobial activity was tested in vitro against various bacterial pathogens. Immune cell populations in blood, bursa, and spleen were analyzed by flow cytometry.

Foodborne illness from poultry products — especially Salmonella — sickens millions of people annually. This study demonstrates a fundamentally different approach: rather than treating contamination after the fact, antimicrobial peptides are produced by the chickens themselves, reducing pathogens in meat and eggs from the start. It also shows defensins can modulate the birds' immune systems, providing a dual benefit.

This research sits at the intersection of antimicrobial peptide biology and agricultural biotechnology. Defensins are a major class of innate immune peptides found across all vertebrates, and understanding how overexpression affects both direct pathogen killing and immune modulation has implications beyond poultry. It demonstrates the real-world applicability of antimicrobial peptides in food safety, a growing concern as antibiotic resistance makes traditional approaches less effective.

This study used genetically modified chickens, which face significant regulatory and public acceptance barriers in most countries. The antimicrobial testing was primarily done in vitro, and real-world food production conditions may differ. Long-term effects of peptide overexpression on chicken health, welfare, and production performance were not fully characterized. Whether bacteria could develop resistance to these overexpressed peptides over time was not addressed.